Results of physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

Supplementary Material for: Adult Patients with Hbs-Only Phenotype of Sickle Cell Disease have a Decreased Arginine/Asymmetric Dimethylarginine Ratio by figshare admin karger (2628495)

Facilities offering modern family planning services by division in 2014 (A) and 2017 (B). by Rajon Banik (12066099)

Subjects:

Modern family planning service readiness score by division in 2014 (A) and 2017 (B). by Rajon Banik (12066099)

Subjects:

Table 1_Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study.docx by Weijie Wang (247184)

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

Genera associated with FC, symptom score or week to treatment. by Katrine Carlsen (5477300)

Subjects:

Patient demographics. by Katrine Carlsen (5477300)

Subjects:

Alpha diversity measures across all 727 samples. by Katrine Carlsen (5477300)

Subjects:

STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

Subjects:

Table 3_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.docx by Linda S. Barter (21466916)

Image 2_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg by Linda S. Barter (21466916)

Image 1_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg by Linda S. Barter (21466916)

S5 Fig - by Katrine Carlsen (5477300)

Subjects:

Association across weeks to treatment for three genera. by Katrine Carlsen (5477300)

Subjects:

Microbiome profile of the most abundant phyla in one patient (Patient 1), across 12 infliximab treatments (-1 is the week before treatment, -2 the two weeks before treatment, etc). by Katrine Carlsen (5477300)

Subjects:

Supplementary file 1_Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.docx by Emmama Jamil (22005635)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects: